Lionco Pharmaceutical Group Co.,Ltd. (SHA:603669)

China flag China · Delayed Price · Currency is CNY
4.480
-0.070 (-1.54%)
Apr 30, 2026, 3:00 PM CST
4.43%
Market Cap 3.16B
Revenue (ttm) 322.48M
Net Income (ttm) -193.24M
Shares Out 694.63M
EPS (ttm) -0.27
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 13,176,800
Average Volume 23,213,237
Open 4.510
Previous Close 4.550
Day's Range 4.460 - 4.600
52-Week Range 4.020 - 7.050
Beta 0.33
RSI 48.99
Earnings Date Apr 25, 2026

About SHA:603669

Lionco Pharmaceutical Group Co.,Ltd., together with its subsidiaries, engages in the research, development, production, and sale of pharmaceutical products and medical services in China. It offers chemical and prescription drugs for nutrition, antimicrobial, antiviral, digestive, cardiovascular, cerebrovascular, detoxification, anti-tumor, and other applications. The company was founded in 2003 and is based in Shannan, China. [Read more]

Sector Healthcare
Founded 2003
Employees 436
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 603669
Full Company Profile

Financial Performance

In 2025, SHA:603669's revenue was 322.48 million, a decrease of -15.09% compared to the previous year's 379.78 million. Losses were -193.24 million, 47.8% more than in 2024.

Financial Statements

News

There is no news available yet.